AGA. C. Gula
A. C. Gula
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
A. C. Gula has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
A. A. Sonzogni
National Nuclear Data Center, Brookhaven National Laboratory, Upton, New York 11973, USA
1 shared publicationA. Lepailleur
Rutgers State Univ, Dept Phys & Astron, New Brunswick, NJ 08903 USA
1 shared publicationA. Radich
Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada
1 shared publicationA.C. Shotter
Univ Edinburgh, Sch Phys & Astron, JCMB, Mayfield Rd, Edinburgh EH9 3JZ, Midlothian, Scotland
1 shared publication- Athanasios Psaltis
Saint Mary's University
1 shared publication B. Davids
TRIUMF, Vancouver, BC V6T 4A3, Canada
1 shared publication
Latest Publications
- 1 February 2022
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
- Vol. 512, 6-11
Use of Bayesian Optimization to understand the structure of nuclei
- 1 February 2022
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
- Vol. 512, 6-11
Use of Bayesian Optimization to understand the structure of nuclei
- 11 September 2020
- Published by American Physical Society (APS) in Physical Review C
- Vol. 102 (3) , 034316
State-of-the-art -ray assay of for medical imagingAn emerging direction in nuclear medicine is the coupling of a therapeutic isotope with an imaging isotope to form a so-called theranostic pair, which allows one to quantitatively track and image the delivery of the therapeutic isotope. is used in several therapy applications and a convenient candidate imaging partner is the positron emitter . A 27.6 MBq source of was produced at the University of Wisconsin and assayed with the Gammasphere array at Argonne National Laboratory. Over 200 -ray transitions were identified, more than double that which was previously known. The positron emission probability inferred from the present level scheme leads to 27.9(12)%, an important reduction with respect to the previously recommended value.- 11 September 2020
- Published by American Physical Society (APS) in Physical Review C
- Vol. 102 (3) , 034316
State-of-the-art -ray assay of for medical imagingAn emerging direction in nuclear medicine is the coupling of a therapeutic isotope with an imaging isotope to form a so-called theranostic pair, which allows one to quantitatively track and image the delivery of the therapeutic isotope. is used in several therapy applications and a convenient candidate imaging partner is the positron emitter . A 27.6 MBq source of was produced at the University of Wisconsin and assayed with the Gammasphere array at Argonne National Laboratory. Over 200 -ray transitions were identified, more than double that which was previously known. The positron emission probability inferred from the present level scheme leads to 27.9(12)%, an important reduction with respect to the previously recommended value.